Multimorbidity in the era of increasing life expectancy and aging population

European Journal of Heart FailureEarly View Invited Editorial Multimorbidity in the era of increasing life expectancy and aging population Nikhil Patel, Nikhil Patel Division of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USASearch for more papers by this authorJoseph Yeboah, Corresponding Author Joseph Yeboah [email protected] Division of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA Corresponding author. Heart and Vascular Center of Excellence, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA. Tel. +1 336 716-7015, Fax +1 336 716-9188, Email: [email protected]Search for more papers by this author Nikhil Patel, Nikhil Patel Division of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USASearch for more papers by this authorJoseph Yeboah, Corresponding Author Joseph Yeboah [email protected] Division of Cardiovascular Medicine, Department of Internal Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA Corresponding author. Heart and Vascular Center of Excellence, Wake Forest School of Medicine, Medical Center Blvd., Winston-Salem, NC 27157, USA. Tel. +1 336 716-7015, Fax +1 336 716-9188, Email: [email protected]Search for more papers by this author First published: 11 April 2024 https://doi.org/10.1002/ejhf.3243 The opinions expressed in this article are not necessarily those of the Editors of the European Journal of Heart Failure or of the European Society of Cardiology. doi: 10.1002/ejhf.3112. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GM, Coats AJ. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res 2022; 118: 3272–3287. https://doi.org/10.1093/cvr/cvac013 10.1093/cvr/cvac013 CASWeb of Science®Google Scholar 2Yin HL, Yin S, Lin QY, Xu Y, Xu HW, Liu T. Prevalence of comorbidities in chronic obstructive pulmonary disease patients: A metaanalysis. Medicine (Baltimore) 2017; 96:e6836. https://doi.org/10.1097/MD.0000000000006836 10.1097/MD.0000000000006836 PubMedWeb of Science®Google Scholar 3Gerhardt T, Gerhardt LM, Ouwerkerk W, Roth GA, Dickstein K, Collins SP, et al. Multimorbidity in patients with acute heart failure across world regions and country income levels (REPORT-HF): A prospective, multicentre, global cohort study. Lancet Glob Health 2023; 11: e1874–e1884. https://doi.org/10.1016/S2214-109X(23)00408-4 10.1016/S2214-109X(23)00408-4 CASPubMedGoogle Scholar 4Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2022; 79: 1757–1780. https://doi.org/10.1016/j.jacc.2021.12.011 10.1016/j.jacc.2021.12.011 PubMedGoogle Scholar 5McDonagh T, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al.; ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022; 24: 4–131. https://doi.org/10.1002/ejhf.2333 10.1002/ejhf.2333 PubMedWeb of Science®Google Scholar 6de Jonge N, Kirkels JH, Klöpping C, Lahpor JR, Caliskan K, Maat APWM, et al. Guidelines for heart transplantation. Neth Heart J 2008; 16: 79–87. https://doi.org/10.1007/BF03086123 10.1007/BF03086123 PubMedWeb of Science®Google Scholar 7Tomasoni D, Vitale C, Guidetti F, Benson L, Braunschweig F, Dahlström U, et al. The role of multimorbidity in patients with heart failure across the left ventricular ejection fraction spectrum: Data from the Swedish Heart Failure Registry. Eur J Heart Fail. https://doi.org/10.1002/ejhf.3112 Published online ahead of print 22/12/23. 10.1002/ejhf.3112 Web of Science®Google Scholar 8Dewan P, Ferreira JP, Butt JH, Petrie MC, Abraham WT, Desai AS, et al. Impact of multimorbidity on mortality in heart failure with reduced ejection fraction: Which comorbidities matter most? An analysis of PARADIGM-HF and ATMOSPHERE. Eur J Heart Fail 2023; 25: 687–697. https://doi.org/10.1002/ejhf.2856 10.1002/ejhf.2856 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation